News
New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...
For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...
4d
Tennis World USA on MSNPatrick Mouratoglou explains the reason behind Novak Djokovic's foot problemNovak Djokovic also made it through the second round of the 2025 Roland Garros, beating local idol Corentin Moutet in three ...
6d
The Healthy @Reader's Digest on MSN4 Types of Toenail Fungus and How To Treat ThemIt can take up to a year for toenail fungus to completely resolve with treatment, and it can come back without proper ...
77% of patients with genital psoriasis achieved a static Physician's Global Assessment of Genitalia (sPGA-G) d score of 0/1 compared to 21% receiving placebo (P<0.001) at 16 weeks. In the smaller ...
According to Everyday Health, foot psoriasis is a type of psoriasis, which causes painful, itchy, red, dry patches of skin on the bottom or soles of your feet. A more rare form of the condition, ...
Dark coloured spots can be possible melanomas. These can appear in the skin - top and bottom of feet and nails. Please speak to a medical professional or better yet get a skin check as soon as ...
Hand and foot psoriasis impairs patients´ ability to function, impacts them financially, and chips away at their self-worth. Dermatology nurses play an important role with these patients in ...
They can happen anywhere on your body. The soles of the feet are commonly affected. The patches caused by psoriasis are an overgrowth of skin cells. The cause is unknown, but psoriasis is most ...
psoriasis on both knees about 2%, and the chest about 5-6%, said Asempa. Involvement of problematic areas -- scalp, intertriginous sites, soles of the feet -- also figures into the assessment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results